IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
search & De vel op ment: Dr Abofele Khoele; Gen -
eral Con tact: Pa tri cia Howe
Par ent of: Ciba Vi sion, South Af rica (100%);
Novartis An i mal Health, South Af rica (100%);
Novartis Con sumer Health, South Af rica (100%).
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 65-70 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 55-60%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
GLEEVEC (antineoplastic other)
TEGRETOL (antiepileptic)
RITALIN (psychostimulant)
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -
tion)
CATAFLAM (antirheumatic non-steroidal)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 17%
anti rheu ma tics sys temic 13%
antiepileptics 10%
antineoplastics 10%
psychoanaleptics 10%
Lead ing Dose Forms:
coated tab lets 39%
tab lets 25%
cap sules 14%
am poules 7%
in fu sions 6%
NOVARTIS AN I MAL HEALTH
Postal Ad dress: PO Box 92, Kemp ton Park
1600, Gauteng
Sub sid iary of: Novartis, South Af rica (100%)
NOVARTIS CON SUMER HEALTH
Full Name: Novartis South Af rica (Pty) Ltd
Postal Ad dress: Pri vate Bag 92, Kemp ton Park,
Gauteng 1600
Street Ad dress: 72 Steel Road, Spar tan, Kemp -
ton Park 1619, Gauteng
Tel: +27 11 929-9111
Fax: +27 11 929-2063
Home Page: www.novartis.com
De scrip tion: Re searcher, de vel oper, man u fac -
turer, for mu la tor, packager/as sem bler, im porter,
ex porter, dis trib u tor, pro moter, sales/detailer.
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion, non-pre scrip tion), hos pi -
tal pharmaceuticals, di etetic/nu tri tional prod ucts,
oph thal mic prod ucts, op ti cal in stru ments, vet er i -
nary pharmaceuticals. Es tab lished 1997. 35 phar -
ma ceu ti cal em ploy ees in 2005. Di vi sions in clude:
Pharmaceuticals; OTC; Ciba Vision; Animal
Health; Sandoz Generics.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 18 (2005)
Con tacts (Pharm): Chair man: Hilton Loring;
Com mer cial Op er a tions: Rob ert Lee (Sales),
Michelle Wat son (Mar ket ing); Man u fac ture:
Tanya Aboo; Mar ket Re search: Michelle Wat son;
Re search & De vel op ment: Luvuyo Ngoma; Gen -
eral Con tact: Lindie Gerber
Sub sid iary of: Novartis, South Af rica (100%)
Phar ma ceu ti cal Sales: US$ 14-16 mil lion
Prod ucts (% of Sales by Lead ing 5): 55-60%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
VOLTAREN EMULGEL (antirheumatic top i cal)
LAMISIL TOP I CAL (dermatological antifungal)
VIBROCIL (na sal prep a ra tion top i cal)
DEGORAN PLUS (cold prep a ra tion with out anti-in -
fec tive)
OTRIVIN (na sal prep a ra tion top i cal)
Ther a peu tic Range:
na sal prep a ra tions 22%
anti rheu ma tics top i cal 18%
dermatological antifungals 14%
min eral sup ple ments 11%
cough and cold prep a ra tions 10%
Lead ing Dose Forms:
liq uids 24%
gels/sols 23%
coated tab lets 18%
tab lets 15%
creams 11%
SANDOZ
Postal Ad dress: PO Box 154, Isando, Kemp ton
Park, Gauteng 1600
Street Ad dress: 72 Steel Road, Spar tan, Kemp -
ton Park 1619, Gauteng
Tel: +27 11 929-9000
Fax: +27 11 929-9015
Home Page: www.sandoz.co.za
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 65-70 mil lion
Prod ucts (% of Sales by Lead ing 5): 20-25%
Ther a peu tic Classes (% of Sales by Lead ing
5): 45-50%
© 2009 IMS Health In cor po rated or its af fil i ates Page 207